Appeal 2006-1971 Application 10/144,224 1 hemoglobin (col. 4, ll. 11-22). Appellants do not dispute the Examiner's 2 holding, but rather argues the Gravenstein does not teach the depth 3 penetration or the claimed separation distance and repeats the same 4 arguments presented for claim 1. Thus, we find that Appellants fail to 5 address the portions of the reference relied upon by the Examiner. 6 Accordingly, we are not convinced of any error on the part of the 7 Examiner in rejecting claims 14-16. The rejection of claims 14-16 under 8 35 U.S.C. § 103(a) is sustained. 9 We turn next to the rejection of claim 12 under 35 U.S.C. § 103(a) as 10 being unpatentable over Steuer, Soller, Arakaki, Aranow, Gravenstein and 11 Osemwota. The examiner additionally relies upon Osemwota for a 12 suggestion of using an invasive measurement to initially calibrate the 13 instruments. Appellants do not argue the portions of Osemwota relied upon 14 by the Examiner. Rather, Appellants assert (Br. 20-22) that Osemwota does 15 not teach or suggest the claimed penetration depth and separation distance, 16 and repeats the arguments made for claim 1. From our findings, supra, with 17 respect to the suggestions of Osemwota and the failure of Appellants to 18 argue the portions of the reference relied upon by the Examiner, we hold that 19 the prior art would have suggested the language of claim 12 and are not 20 persuaded of any error on the part of the Examiner. The rejection of claim 12 21 under 35 U.S.C. § 103(a) is sustained. 22 We turn next to the rejection of claim 20 under 35 U.S.C. § 103(a) as 23 being unpatentable over Steuer, Soller, Arakaki, Aronow, Mendelson, Mills, 24 and Misner. The Examiner additionally relies upon Misner for a suggestion 25 15Page: Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Last modified: September 9, 2013